| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 181.45 | n/a |
| Intrinsic value (DCF) | 0.97 | n/a |
| Graham-Dodd Method | n/a | |
| Graham Formula | 350.60 | n/a |
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.